Cancer Therapeutics The Worldwide Market 2nd Edition

Countries covered: Global

Few pharmaceutical markets will see the dramatic change that will occur in cancer therapeutics over the next four years. More than $8 billion dollars worth of new products are expected in the next four years, impacting the treatment of cancer in ways that product managers, strategic planners, business development managers and marketing executives will need to be aware of.

Between 2004 and 2006, the market for cancer therapeutics saw more than an 18% increase, presaging future growth. Given the promising therapy pipeline and increasing incidence of cancer, double-digit growth is expected annually, leading to opportunities for current players and new entrants alike.

Kalorama's Cancer Therapeutics: The Worldwide Market is your guide to a $45 billion dollar cancer treatment market that is expected to double in the next four years. Kalorama’s detailed report includes the following:

Current Market Size and Revenue Forecasts for each market segment for long-term strategic business planning.

Round-Up of the Key Players in the Cancer Therapeutics Market

The Collective Market Knowledge of over 65 Market Insiders interviewed for this report.

Identification of the Fastest Growing Areas of Cancer Therapy so that marketers can make strategic adjustments or consider new products.

Over 160 Tables and Figures for decision support and internal emails, memos and presentations.

Discussion of 17 Issues and Trends critical to understanding this Market and assessing opportunities.

In this second edition, Kalorama builds on the success of the first edition of Cancer Therapeutics: The Worldwide Market, which correctly anticipated the growth of this market over the previous years. Since the last edition, there's been more changes in cancer treatment, especially in the area of immunobiological treatments for cancer. Kalorama details that change in this edition.

This study breaks down the cancer therapeutics market by therapy type, reporting and forecasting revenues from 2004 through 2011 in the following area:

Chemotherapy

Hormone Therapy

Radiation Therapy

Immunotherapy and Biotherapy, and

Adjunctive Therapies

A truly global report, The Worldwide Market for Cancer Therapeutics breaks down the market for cancer therapeutics in the United States, Europe, Japan and the Rest of the World in detail.

The study focuses on current and emerging markets, products in development, and trends affecting the cancer treatment market. Demographic and epidemiological data are presented for the major cancer types, therapies in development are reviewed by development stage and earliest possible approval date, and profiles of the leading and significant competitors are included for reference.

Bladder

Breast

Cervical

Colorectal

Esophageal

Head/Neck

Kidney

Leukemia

Liver

Lung

Lymphoma

Melanoma

Multiple Myeloma

Neuroblastoma

Ovarian

Pancreatic

Prostate

Stomach

As part of Kalorama's trusted information-gatehring process, information for this report is drawn from company reports, government data and medical journals, then checked and cross-referenced extensively with experts in the cancer therapeutics industry. Interviews are the main source of market insights and forecasts.

Companies covered in this exhaustive report include:

Amgen

AstraZeneca plc

Biogen IDEC, Inc.

Bristol-Myers Squibb Company/Oncology

Eli Lilly & Company

Genentech, Inc.

GlaxoSmithKline plc

Johnson & Johnson Group

Merck & Company, Inc.

Novartis Pharmaceuticals

Pfizer, Inc.

Roche

Sanofi-Aventis

Schering-Plough

TAP Pharmaceutical Products

February 1, 2007

545 Pages - Pub ID: KLI1365882 Format PDF
Table of Contents
Price: $3,995.00 / GBP2,197.25